Clinic
Memorial Hermann Health System
Memorial Hermann Health System was paid $26.79M by Medicaid between Oct 2019 and Dec 2024, across 90 billing codes. Its largest line is 99284, emergency room visit (serious) — 51% of everything it billed.
33Billing provider infoMEMORIAL HERMANN HEALTH SYSTEM
HUMBLE, TX 77338
HUMBLE, TX 77338
33aNPI1295843787assigned 08/26/2006
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$26.79M
24GClaims262,616
24DCodes billed90
24AFirst – last monthOct 2019 – Dec 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Texas
Rank by total paid#18 of 320
Median peer was paid$205K
This provider vs. median131×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LARAWAY, DENNIS controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 185 | $1K | |
| 2020 | 4,350 | $797K | |
| 2021 | 58,657 | $6.68M | |
| 2022 | 81,198 | $7.37M | |
| 2023 | 78,864 | $8.56M | |
| 2024incomplete | 39,362 | $3.39M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 51% | 28,556 | 27,114 | $13.75M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 11% | 26,090 | 25,309 | $3.02M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.5% | 5,236 | 4,863 | $2.54M |
| 80053 | Comprehensive metabolic panel | 5.1% | 23,555 | 21,760 | $1.37M |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 4.0% | 9,705 | 9,007 | $1.08M |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.8% | 29,975 | 27,283 | $746K |
| 81001 | 2.4% | 24,200 | 22,905 | $652K | |
| 71045 | Radiologic examination, chest; single view | 2.1% | 11,448 | 10,851 | $555K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.8% | 11,859 | 11,517 | $477K |
| 87400 | 1.7% | 11,550 | 5,730 | $449K | |
| 83690 | 1.2% | 8,967 | 8,388 | $332K | |
| 84484 | <1% | 6,908 | 5,014 | $232K |
78 more codes
| 93975 | <1% | 1,032 | $227K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 788 | $163K |
| 84703 | <1% | 3,849 | $152K | |
| 76801 | <1% | 1,051 | $108K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,081 | $83K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 839 | $74K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 2,131 | $68K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 919 | $57K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,424 | $44K |
| 84702 | <1% | 1,806 | $40K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,427 | $40K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,062 | $38K |
| 82550 | <1% | 2,533 | $34K | |
| 84450 | <1% | 879 | $33K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 4,830 | $32K |
| 84075 | <1% | 883 | $30K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 314 | $28K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 629 | $28K |
| 85610 | <1% | 4,854 | $27K | |
| 85730 | <1% | 4,738 | $26K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 280 | $20K |
| 83880 | <1% | 1,443 | $19K | |
| 82247 | <1% | 882 | $19K | |
| 81025 | <1% | 703 | $18K | |
| 87807 | <1% | 586 | $16K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 481 | $15K |
| 84155 | <1% | 878 | $15K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,186 | $15K |
| 87081 | <1% | 623 | $15K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 981 | $14K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,302 | $13K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 139 | $11K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 29 | $8K |
| 82040 | <1% | 873 | $5K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 314 | $4K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 149 | $4K |
| J3490 | Unclassified drugs | <1% | 840 | $4K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 50 | $4K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 28 | $3K |
| 86900 | <1% | 1,166 | $2K | |
| 83735 | <1% | 1,244 | $2K | |
| 86901 | <1% | 1,164 | $2K | |
| 80076 | <1% | 79 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,967 | $2K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 24 | $2K |
| 36000 | <1% | 246 | $2K | |
| 84145 | <1% | 184 | $1K | |
| G0257 | Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility | <1% | 20 | $1K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 315 | $1K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 14 | $1K |
| 83605 | <1% | 384 | $1K | |
| 87186 | <1% | 284 | $1K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 16 | $1K |
| 86850 | <1% | 106 | $957.45 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 685 | $904.64 |
| 96376 | <1% | 123 | $748.29 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,348 | $729.81 |
| 74018 | <1% | 12 | $632.92 | |
| 84100 | <1% | 655 | $582.17 | |
| 82077 | <1% | 26 | $230.26 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 446 | $225.56 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 774 | $204.37 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 231 | $190.57 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 80 | $168.89 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 151 | $161.04 |
| 82947 | <1% | 417 | $150.86 | |
| 87077 | <1% | 28 | $137.74 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 87 | $112.74 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 83 | $82.49 |
| 85027 | <1% | 32 | $59.38 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 32 | $44.73 |
| 87040 | <1% | 17 | $37.62 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 13 | $30.82 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 14 | $20.13 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | <1% | 13 | $18.20 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 194 | $14.21 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 40 | $4.17 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLARAWAY, DENNIS (CFO)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.